{"organizations": [], "uuid": "43d8c148546e90442d0d0e80001425044ef63704", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180220.html", "section_title": "Archive News &amp; Video for Tuesday, 20 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-ionis-licences-new-antisense-drug/brief-ionis-licences-new-antisense-drug-for-kidney-disease-to-astrazeneca-idUSFWN1QA0JQ", "country": "US", "domain_rank": 408, "title": "BRIEF-Ionis Licences New Antisense Drug For Kidney Disease To Astrazeneca", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.998, "site_type": "news", "published": "2018-02-20T20:14:00.000+02:00", "replies_count": 0, "uuid": "43d8c148546e90442d0d0e80001425044ef63704"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-ionis-licences-new-antisense-drug/brief-ionis-licences-new-antisense-drug-for-kidney-disease-to-astrazeneca-idUSFWN1QA0JQ", "ord_in_thread": 0, "title": "BRIEF-Ionis Licences New Antisense Drug For Kidney Disease To Astrazeneca", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "astrazeneca", "sentiment": "negative"}, {"name": "reuters) - ionis pharmaceuticals inc", "sentiment": "neutral"}, {"name": "pharmaceuticals inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - Ionis Pharmaceuticals Inc:\n* IONIS LICENCES NEW ANTISENSE DRUG FOR KIDNEY DISEASE TO ASTRAZENECA\n* IONIS PHARMACEUTICALS INC SAYS ‍IT HAS LICENSED IONIS-AZ5-2.5(RX) (AZD2373) TO GLOBAL, SCIENCE-LED BIOPHARMACEUTICAL COMPANY ASTRAZENECA​\n* IONIS PHARMACEUTICALS INC - ‍IONIS WILL RECEIVE A $30 MILLION UPFRONT PAYMENT FROM ASTRAZENECA FOR IONIS-AZ5-2.5(RX)​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-20T20:14:00.000+02:00", "crawled": "2018-02-21T21:36:01.015+02:00", "highlightTitle": ""}